OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3‐d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR‐2 inhibition, and down‐regulation of PI3K/AKT/mTOR signaling pathway
Safaa E. Seif, Zeinab Mahmoud, Wagnat W. Wardakhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 839-860
Closed Access | Times Cited: 13
Safaa E. Seif, Zeinab Mahmoud, Wagnat W. Wardakhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 839-860
Closed Access | Times Cited: 13
Showing 13 citing articles:
QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking
Hao Ding, Fei Xing, Lin Zou, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Hao Ding, Fei Xing, Lin Zou, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulation
Moustafa S. Abusaif, Ahmed Ragab, Eman A. Fayed, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108023-108023
Closed Access | Times Cited: 3
Moustafa S. Abusaif, Ahmed Ragab, Eman A. Fayed, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108023-108023
Closed Access | Times Cited: 3
Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3‐d]pyrimidine derivatives as EGFR inhibitors
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1299-1319
Closed Access | Times Cited: 8
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1299-1319
Closed Access | Times Cited: 8
Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking
Walid E. Elgammal, Safaa S. Shaban, Essam M. Eliwa, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1219-1237
Closed Access | Times Cited: 2
Walid E. Elgammal, Safaa S. Shaban, Essam M. Eliwa, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1219-1237
Closed Access | Times Cited: 2
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Design, synthesis, and biological evaluation of novel thiazole derivatives as PI3K/mTOR dual inhibitors.
Samar I. Faggal, Yara El‐Dash, Amr Sonousi, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Samar I. Faggal, Yara El‐Dash, Amr Sonousi, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Pyridine and Pyrimidine hybrids as privileged scaffolds in antimalarial drug discovery: A recent development
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129992-129992
Closed Access | Times Cited: 1
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129992-129992
Closed Access | Times Cited: 1
New S‐substituted‐3‐phenyltetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B‐RAF signaling pathway
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 1
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 1
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Danhong injection alleviates OGD-induced blood-brain barrier injury via VEGFR2/PI3K/AKT pathway based on network pharmacology and experimental evidence
Yutong Zhang, Meixia Xie, Jiayin Liang, et al.
Journal of Holistic Integrative Pharmacy (2024) Vol. 5, Iss. 1, pp. 10-18
Open Access
Yutong Zhang, Meixia Xie, Jiayin Liang, et al.
Journal of Holistic Integrative Pharmacy (2024) Vol. 5, Iss. 1, pp. 10-18
Open Access
Biochemical Pathways Delivering Distinct Glycosphingolipid Patterns in MDA-MB-231 and MCF-7 Breast Cancer Cells
Anita Markotić, Jasminka Omerović, Sandra Marijan, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10200-10217
Open Access
Anita Markotić, Jasminka Omerović, Sandra Marijan, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10200-10217
Open Access
Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mohamed E. Mahmoud, Eman Ahmed, Hamdy M. Ragab, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30346-30363
Open Access
Mohamed E. Mahmoud, Eman Ahmed, Hamdy M. Ragab, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30346-30363
Open Access
Advances in structural identification of some thieno[2,3-d]pyrimidine scaffolds as antitumor molecules: Synthetic approaches and control programmed cancer cell death potential
Aml E.-S. Mghwary, Rasha A. Hassan, Peter A. Halim, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107985-107985
Closed Access
Aml E.-S. Mghwary, Rasha A. Hassan, Peter A. Halim, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107985-107985
Closed Access
